Pfizer Inc.
PFE
$27.05
$0.291.08%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 06/28/2026 | 03/29/2026 | 12/31/2025 | 09/28/2025 | 06/29/2025 | |
|---|---|---|---|---|---|
| Net Income | -247.00M | 2.69B | -1.65B | 3.54B | -- |
| Total Depreciation and Amortization | 1.61B | 1.61B | 1.66B | 1.66B | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.29B | 50.00M | 3.75B | -561.00M | -- |
| Change in Net Operating Assets | -1.82B | -1.73B | 1.59B | -36.00M | -- |
| Cash from Operations | 835.00M | 2.62B | 5.35B | 4.60B | -- |
| Capital Expenditure | -533.00M | -436.00M | -845.00M | -602.00M | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -6.93B | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.64B | 1.22B | 1.63B | -1.83B | -- |
| Cash from Investing | 2.11B | 785.00M | -6.15B | -2.43B | -- |
| Total Debt Issued | -- | -- | 5.99B | 0.00 | -- |
| Total Debt Repaid | -1.19B | -127.00M | -2.91B | 6.00M | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -2.45B | -2.45B | -2.45B | -2.44B | -- |
| Other Financing Activities | -26.00M | -284.00M | -44.00M | -39.00M | -- |
| Cash from Financing | -3.66B | -2.86B | 596.00M | -2.48B | -- |
| Foreign Exchange rate Adjustments | -4.00M | 19.00M | 5.00M | 2.00M | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | 2.00M | -- |
| Net Change in Cash | -726.00M | 563.00M | -197.00M | -300.00M | -- |